EnsiliTech

EnsiliTech is a biotechnology startup based in Bristol, UK, founded in 2022 as a spin-out from the University of Bath. The company specializes in the thermostabilization of biopharmaceuticals using its proprietary Ensilication® platform technology. This innovative process encases thermally unstable biomolecules, such as vaccines and antibodies, within a biocompatible silica network. This allows for storage and transport at temperatures ranging from -80°C to +50°C without the need for refrigeration.

EnsiliTech addresses significant challenges in biopharmaceutical logistics, including cold chain failures that lead to substantial industry losses and environmental impact. The technology not only reduces costs and waste but also improves access to essential medicines in low-resource areas. The company has received recognition for its innovation, winning multiple awards and securing significant funding to support its growth. EnsiliTech is actively seeking partnerships with vaccine and antibody developers, producers, and investors to further its mission in the biopharmaceutical sector.